NCT04827368View on ClinicalTrials.gov

Volatile Organic Compounds (VOCs) in Active Inflammatory Bowel Disease

Active, not recruitingOBSERVATIONAL
Enrollment

292

Participants

Timeline

Start Date

March 22, 2021

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
IBDCrohn DiseaseUlcerative Colitis
Interventions
OTHER

Breath Test

Research Breath sample through disposable mouth filter. Serum sample through routine blood draw. Stool sample through standard collection containers.

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

Sponsors

Collaborators (1)

AbbVie
All Listed Sponsors
collaborator

AbbVie

INDUSTRY

lead

The Cleveland Clinic

OTHER